Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Rebecca Robbins

Physician Assistant Dallastown, PA Physician Assistant

NPI 1083786263 CMS profile 11162988

1010 Blymire Rd, Dallastown, PA 17313

Open in the dashboard

General payments

$7,428

445 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rebecca Robbins of Dallastown, PA is reported in the CMS Open Payments database as having received $7,428 across 445 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,688 87
2024 General $1,588 85
2023 General $1,396 93
2022 General $1,554 103
2021 General $1,203 77

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rebecca Robbins
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Rebecca Robbins were reported at $1,688. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Rebecca Robbins Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,203 $132 $37–$438 $132
2022 $1,554 $155 $48–$522 $149
2023 $1,396 $167 $52–$557 $160
2024 $1,588 $178 $55–$600 $164
2025 $1,688 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. GlaxoSmithKline, LLC. $840 53 payments
  2. Novo Nordisk Inc $820 53 payments
  3. AbbVie, Inc. $770 43 payments
  4. Pfizer Inc. $664 61 payments
  5. AstraZeneca Pharmaceuticals LP $653 37 payments
  6. Lilly USA, LLC $568 34 payments
  7. Astellas Pharma US Inc $272 8 payments
  8. Amgen Inc. $232 13 payments
  9. Janssen Pharmaceuticals, Inc $217 12 payments
  10. Salix Pharmaceuticals, a division of Bausch Health US, LLC $212 12 payments
  11. Other $2,182 119 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $7,264 442 payments
  2. Education $164 3 payments
Products named General payments · program years 2021–2025
  1. TRELEGY ELLIPTA $615 33 payments
  2. Ozempic $602 40 payments
  3. RYBELSUS $554 38 payments
  4. FARXIGA $410 24 payments
  5. NURTEC ODT $366 26 payments
  6. MOUNJARO $316 19 payments
  7. VRAYLAR $307 17 payments
  8. SHINGRIX $283 22 payments
  9. QULIPTA $269 13 payments
  10. AIRSUPRA $233 10 payments
  11. Other $6,372 426 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 59 drugs

Part D claims

1,733

Median for Physician Assistant: 241

Drug cost

$104,479

Median for Physician Assistant: $4,110

Branded share of claims

15.8%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Trulicity Dulaglutide Brand 21 $22,473
Ozempic Semaglutide Brand 15 $21,922
Eliquis Apixaban Brand 22 $18,614
Farxiga Dapagliflozin Propanediol Brand 21 $18,613
Breo Ellipta Fluticasone/Vilanterol Brand 15 $5,850
Fluticasone-Salmeterol Fluticasone Propion/Salmeterol Brand 22 $2,274
Valsartan Generic 48 $1,727
Atorvastatin Calcium Generic 174 $1,553
Synthroid Levothyroxine Sodium Brand 12 $812
Diclofenac Sodium Generic 17 $773

The 10 drugs with the highest cost, of 59 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 81 billing codes

Paid by Medicare

$54,173

Of which drugs: $9,141

Medicare patients

210

Average age 74

Services billed

2,689

142 women, 68 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 63%
Arthritis 47%
Diabetes 26%
Chronic kidney disease 23%
Ischemic heart disease 20%
Depression 20%
COPD 15%
Atrial fibrillation 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Sarscv2 vac 30mcg trs-suc im 91320 Office 29 31 $4,482
Influenza vaccine, trivalent derived from recombinant dna 90673 Office 36 36 $2,837

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 32 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
TRELEGY ELLIPTA
  • GlaxoSmithKline, LLC. $140
$140 — —
AIRSUPRA
  • AstraZeneca Pharmaceuticals LP $100
$100 — —
JARDIANCE
  • Boehringer Ingelheim Pharmaceuticals, Inc. $60
  • Lilly USA, LLC $34
$94 — —
MOUNJARO
  • Lilly USA, LLC $89
$89 — —
VOQUEZNA
  • Phathom Pharmaceuticals, Inc. $87
$87 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 32 with Patron

Records

445 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record